Regenerative Medicines: Development Slowed By Lack of Standardization, Regulatory And Manufacturing Challenges

 
• By Sue Sutter
  
Arrows
GAO offers policy options aimed at overcoming development challenges for regenerative medicines. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Cell & Gene Therapies

More from Advanced Technologies